iifl-logo

Dr Reddys Laboratories Ltd Historical Data

1,234.5
(-1.12%)
Oct 8, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Dr Reddys Laboratories Ltd Historical Data

08/09/2025calendar-icon
08/10/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

08-Sep-2025

1,269

1,2771,248.71,250.642,6571,22,02,42,885.74,57,967

09-Sep-2025

1,257.5

1,295.81,256.81,291.364,6902,10,66,64,9707,35,849

10-Sep-2025

1,294.4

1,3101,293.71,304.249,0151,60,61,91,212.25,70,462

11-Sep-2025

1,304

1,3111,2831,303.160,7811,75,20,41,228.85,40,945

12-Sep-2025

1,303.1

1,3211,302.81,316.744,9871,37,12,75,880.35,57,262

15-Sep-2025

1,308.9

1,311.81,292.51,300.839,5631,72,90,02,683.16,30,228

16-Sep-2025

1,300

1,312.51,296.41,310.440,0871,35,32,88,759.96,89,625

17-Sep-2025

1,317

1,318.21,305.21,311.430,99493,98,08,182.73,45,761

18-Sep-2025

1,312.1

1,325.81,305.71,322.728,6191,08,29,82,120.74,21,623

19-Sep-2025

1,324.7

1,326.81,3121,321.738,2301,86,17,45,528.49,35,107

22-Sep-2025

1,320.9

1,320.91,293.51,301.439,5311,83,09,40,602.88,74,234

23-Sep-2025

1,300

1,311.91,295.21,308.442,8271,66,17,88,641.77,81,347

24-Sep-2025

1,303.3

1,308.31,294.41,298.139,71197,69,83,088.34,77,718

25-Sep-2025

1,298.3

1,307.31,2681,275.241,5311,59,26,67,477.86,75,001

26-Sep-2025

1,250

1,278.51,246.21,253.185,7682,87,68,13,314.910,35,802

29-Sep-2025

1,265

1,2701,2311,234.693,8354,88,62,31,57225,75,767

30-Sep-2025

1,235.1

1,240.31,217.51,223.787,8223,24,36,15,855.515,66,103

01-Oct-2025

1,227.9

1,250.71,2261,244.776,6625,04,80,64,146.527,05,879

03-Oct-2025

1,243.9

1,265.41,2401,248.160,1793,42,98,21,297.218,10,858

06-Oct-2025

1,248.2

1,251.31,234.21,248.649,0362,33,85,86,644.312,08,019

07-Oct-2025

1,250.3

1,256.11,244.41,248.546,9161,72,64,81,072.49,94,934

Dr Reddys Labs: Related NEWS

US FDA Issues Form 483 With Five Observations at Dr Reddy’s Biologics Facility

The inspection, conducted between September 4 and September 12, 2025, was a pre-approval review.

15 Sep 2025|11:10 AM
Read More
Top Stocks for Today - 15th September 2025

Here are some of the stocks that may see significant price movement today: Apollo Hospitals, GMR Airports, RailTel Corporation, etc.

15 Sep 2025|07:44 AM
Read More
Dr Reddy’s Infuses ₹565 Cr into Russian Arm

The capital was infused via cash and will be used to support DRL Russia’s working capital requirements.

28 Jul 2025|12:22 PM
Read More
Dr Reddy’s Laboratories inks pact with Alvotech; stock gains ~3%

As per the terms agreement, Alvotech and Dr Reddy’s will jointly develop and manufacture the biosimilar candidate and share costs and responsibilities.

5 Jun 2025|11:00 AM
Read More
Dr. Reddy’s Receives Two USFDA Observations for New York API Manufacturing Plant

Issuance of a Form 483 occurs when an investigator(s) has observed any conditions that in their judgment may constitute violations of the FD&C Act and related Acts.

18 May 2025|07:17 PM
Read More
Dr Reddy’s Q4 Profit Jumps 22% to ₹1,594 Crore

The board has recommended a final dividend of ₹8 per equity share for FY 2024–25

12 May 2025|01:00 PM
Read More
Top Stocks for Today - 12th May 2025

Here are some of the stocks that may see significant price movement today: Adani Power, Dr Reddy's, and Bank of India, etc.

12 May 2025|09:32 AM
Read More
Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

5 Mar 2025|11:05 AM
Read More
Top Stocks for - 27th February 2025

Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.

26 Feb 2025|09:22 PM
Read More
Dr Reddy’s Hyderabad API Unit Gets USFDA VAI Classification

Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore. 

25 Feb 2025|08:42 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.